Details for: MTOR

Gene ID: 2475

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: MTOR

Ensembl ID: ENSG00000198793

Description: mechanistic target of rapamycin kinase

Cell Significance Landscape

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • erythroblast CL0000765
    CSI 13.01
    rCSI 34.54%
    PRS 76.04
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI 9.42
    rCSI 33.9%
    PRS 45.34
  • retina horizontal cell CL0000745
    CSI 8.96
    rCSI 13.66%
    PRS 62.03
  • kidney connecting tubule epithelial cell CL1000768
    CSI 7.42
    rCSI 18.81%
    PRS 55.12
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 7.08
    rCSI 17.21%
    PRS 45.51
  • sst GABAergic cortical interneuron CL4023017
    CSI 6.86
    rCSI 8.85%
    PRS 48.3
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 5.19
    rCSI 13.54%
    PRS 65.44
  • mucosal invariant T cell CL0000940
    CSI 4.94
    rCSI 3.99%
    PRS 76.09
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 4.86
    rCSI 8.16%
    PRS 47.04
  • renal interstitial pericyte CL1001318
    CSI 4.52
    rCSI 12.45%
    PRS 60.89
  • L6b glutamatergic cortical neuron CL4023038
    CSI 4.48
    rCSI 14%
    PRS 48.76
  • cerebral cortex neuron CL0010012
    CSI 4.38
    rCSI 17.85%
    PRS 59.33
  • alveolar adventitial fibroblast CL4028006
    CSI 4.17
    rCSI 6.59%
    PRS 68.2
  • fibroblast of cardiac tissue CL0002548
    CSI 3.81
    rCSI 18.27%
    PRS 65.59
  • inhibitory interneuron CL0000498
    CSI 3.59
    rCSI 8.28%
    PRS 54.24
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 3.37
    rCSI 2.56%
    PRS 78.85
  • mesothelial cell CL0000077
    CSI 3.29
    rCSI 12.85%
    PRS 42.5
  • ciliated cell CL0000064
    CSI 3.22
    rCSI 5.22%
    PRS 61.86
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 3.13
    rCSI 1.85%
    PRS 82.77
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 3.11
    rCSI 11.75%
    PRS 47.69
  • double negative thymocyte CL0002489
    CSI 3.04
    rCSI 2.11%
    PRS 76.94
  • IgA plasma cell CL0000987
    CSI 3
    rCSI 3.07%
    PRS 78.59
  • alveolar macrophage CL0000583
    CSI 2.94
    rCSI 4.85%
    PRS 70.92
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI 2.86
    rCSI 16.86%
    PRS 48.22
  • cardiac neuron CL0010022
    CSI 2.75
    rCSI 8.79%
    PRS 62.73
  • pvalb GABAergic cortical interneuron CL4023018
    CSI 2.68
    rCSI 3.34%
    PRS 45.18
  • group 3 innate lymphoid cell CL0001071
    CSI 2.63
    rCSI 1.97%
    PRS 71.38
  • renal alpha-intercalated cell CL0005011
    CSI 2.59
    rCSI 3.46%
    PRS 74.25
  • ependymal cell CL0000065
    CSI 2.59
    rCSI 5.25%
    PRS 44.41
  • naive B cell CL0000788
    CSI 2.58
    rCSI 2.21%
    PRS 73.33
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 2.52
    rCSI 4.44%
    PRS 46.13
  • hepatocyte CL0000182
    CSI 2.47
    rCSI 4.42%
    PRS 65.05
  • interneuron CL0000099
    CSI 2.44
    rCSI 4.89%
    PRS 54.64
  • melanocyte CL0000148
    CSI 2.44
    rCSI 1.8%
    PRS 58.4
  • cerebellar granule cell CL0001031
    CSI 2.42
    rCSI 3.55%
    PRS 58.84
  • vascular leptomeningeal cell CL4023051
    CSI 2.37
    rCSI 4.16%
    PRS 57.85
  • pancreatic D cell CL0000173
    CSI 2.37
    rCSI 2.33%
    PRS 68.5
  • direct pathway medium spiny neuron CL4023026
    CSI 2.36
    rCSI 56.55%
    PRS 46.12
  • neural crest cell CL0011012
    CSI 2.36
    rCSI 1.87%
    PRS 52.55
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 2.35
    rCSI 2.71%
    PRS 58.56
  • indirect pathway medium spiny neuron CL4023029
    CSI 2.35
    rCSI 56.62%
    PRS 46.9
  • Mueller cell CL0000636
    CSI 2.33
    rCSI 5.33%
    PRS 57.3
  • chondrocyte CL0000138
    CSI 2.32
    rCSI 3.7%
    PRS 58.19
  • intestinal tuft cell CL0019032
    CSI 2.28
    rCSI 3.49%
    PRS 69.94
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 2.27
    rCSI 1.53%
    PRS 79.01
  • hepatic stellate cell CL0000632
    CSI 2.22
    rCSI 8.31%
    PRS 57.55
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 2.21
    rCSI 5.72%
    PRS 60.63
  • precursor B cell CL0000817
    CSI 2.16
    rCSI 1.89%
    PRS 74.7
  • pancreatic A cell CL0000171
    CSI 2.13
    rCSI 2.24%
    PRS 69.22
  • ciliated epithelial cell CL0000067
    CSI 2.06
    rCSI 1.81%
    PRS 53.61
  • blood vessel endothelial cell CL0000071
    CSI 2.05
    rCSI 4.25%
    PRS 62.76
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 2.05
    rCSI 1.86%
    PRS 79.88
  • retinal bipolar neuron CL0000748
    CSI 2.01
    rCSI 3.76%
    PRS 53.71
  • astrocyte of the cerebral cortex CL0002605
    CSI 1.99
    rCSI 4.45%
    PRS 47.69
  • naive T cell CL0000898
    CSI 1.98
    rCSI 1.38%
    PRS 80.81
  • retinal rod cell CL0000604
    CSI 1.93
    rCSI 3.4%
    PRS 62.26
  • Kupffer cell CL0000091
    CSI 1.91
    rCSI 4.37%
    PRS 65.73
  • choroid plexus epithelial cell CL0000706
    CSI 1.88
    rCSI 3.09%
    PRS 54.72
  • dopaminergic neuron CL0000700
    CSI 1.88
    rCSI 10.62%
    PRS 50.7
  • renal beta-intercalated cell CL0002201
    CSI 1.88
    rCSI 4.48%
    PRS 66.05
  • granulocyte monocyte progenitor cell CL0000557
    CSI 1.84
    rCSI 1.6%
    PRS 70.67
  • common myeloid progenitor CL0000049
    CSI 1.78
    rCSI 1.44%
    PRS 67.4
  • sncg GABAergic cortical interneuron CL4023015
    CSI 1.76
    rCSI 2.84%
    PRS 49.03
  • VIP GABAergic cortical interneuron CL4023016
    CSI 1.75
    rCSI 2.09%
    PRS 46.8
  • cardiac endothelial cell CL0010008
    CSI 1.74
    rCSI 7.01%
    PRS 64.75
  • class switched memory B cell CL0000972
    CSI 1.71
    rCSI 1.27%
    PRS 81.58
  • cerebral cortex endothelial cell CL1001602
    CSI 1.67
    rCSI 2.88%
    PRS 55.95
  • amacrine cell CL0000561
    CSI 1.64
    rCSI 4.76%
    PRS 55.1
  • conjunctival epithelial cell CL1000432
    CSI 1.62
    rCSI 2.48%
    PRS 66.4
  • epithelial cell of proximal tubule CL0002306
    CSI 1.6
    rCSI 3.9%
    PRS 58.73
  • nasal mucosa goblet cell CL0002480
    CSI 1.56
    rCSI 1.81%
    PRS 72.69
  • lung ciliated cell CL1000271
    CSI 1.52
    rCSI 1.76%
    PRS 56.15
  • common dendritic progenitor CL0001029
    CSI 1.5
    rCSI 1.88%
    PRS 76
  • Bergmann glial cell CL0000644
    CSI 1.49
    rCSI 2.04%
    PRS 58.53
  • glial cell CL0000125
    CSI 1.48
    rCSI 5.65%
    PRS 56.22
  • cardiac muscle cell CL0000746
    CSI 1.46
    rCSI 2.09%
    PRS 55.13
  • lung neuroendocrine cell CL1000223
    CSI 1.43
    rCSI 2.11%
    PRS 70.95
  • type B pancreatic cell CL0000169
    CSI 1.42
    rCSI 3.15%
    PRS 63.84
  • regular ventricular cardiac myocyte CL0002131
    CSI 1.42
    rCSI 8.86%
    PRS 57.34
  • regular atrial cardiac myocyte CL0002129
    CSI 1.41
    rCSI 4.54%
    PRS 63.39
  • basket cell CL0000118
    CSI 1.41
    rCSI 8.8%
    PRS 47.48
  • retinal cone cell CL0000573
    CSI 1.4
    rCSI 2.25%
    PRS 55.19
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 1.38
    rCSI 1.06%
    PRS 66.65
  • L2/3 intratelencephalic projecting glutamatergic neuron CL4030059
    CSI 1.38
    rCSI 2.99%
    PRS 53.24
  • glutamatergic neuron CL0000679
    CSI 1.28
    rCSI 2.63%
    PRS 55.39
  • fibroblast of lung CL0002553
    CSI 1.25
    rCSI 1.16%
    PRS 66.35
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 1.24
    rCSI 1.5%
    PRS 74.47
  • retinal pigment epithelial cell CL0002586
    CSI 1.22
    rCSI 2.43%
    PRS 62.68
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI 1.21
    rCSI 2.19%
    PRS 57.17
  • lung secretory cell CL1000272
    CSI 1.12
    rCSI 2.78%
    PRS 64.21
  • GABAergic neuron CL0000617
    CSI 1.11
    rCSI 3.71%
    PRS 50.51
  • GABAergic amacrine cell CL4030027
    CSI 1.08
    rCSI 3.7%
    PRS 54
  • L5/6 near-projecting glutamatergic neuron CL4030067
    CSI 1.05
    rCSI 3.44%
    PRS 52.43
  • S cone cell CL0003050
    CSI 0.98
    rCSI 4.32%
    PRS 62
  • blood vessel smooth muscle cell CL0019018
    CSI 0.96
    rCSI 7.82%
    PRS 59.1
  • retinal ganglion cell CL0000740
    CSI 0.92
    rCSI 2.02%
    PRS 51.61
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI 0.85
    rCSI 2.66%
    PRS 51.17
  • parietal epithelial cell CL1000452
    CSI 0.8
    rCSI 2.13%
    PRS 56.55
  • central nervous system neuron CL2000029
    CSI 0.62
    rCSI 4.56%
    PRS 52.2
  • neural progenitor cell CL0011020
    CSI 0.57
    rCSI 2.52%
    PRS 55.58
  • medium spiny neuron CL1001474
    CSI 0.2
    rCSI 2.1%
    PRS 52.8%
  • OFF midget ganglion cell CL4033047
    CSI 0.3
    rCSI 6.4%
    PRS 57.6%
  • ON midget ganglion cell CL4033046
    CSI 0.4
    rCSI 8.3%
    PRS 56.2%
  • ON parasol ganglion cell CL4033052
    CSI 0.4
    rCSI 6.1%
    PRS 56.5%
  • neural progenitor cell CL0011020
    CSI 0.6
    rCSI 2.5%
    PRS 55.6%
  • central nervous system neuron CL2000029
    CSI 0.6
    rCSI 4.6%
    PRS 52.2%
  • parietal epithelial cell CL1000452
    CSI 0.8
    rCSI 2.1%
    PRS 56.6%
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI 0.9
    rCSI 2.7%
    PRS 51.2%
  • retinal ganglion cell CL0000740
    CSI 0.9
    rCSI 2.0%
    PRS 51.6%
  • blood vessel smooth muscle cell CL0019018
    CSI 1.0
    rCSI 7.8%
    PRS 59.1%
  • S cone cell CL0003050
    CSI 1.0
    rCSI 4.3%
    PRS 62.0%
  • L5/6 near-projecting glutamatergic neuron CL4030067
    CSI 1.1
    rCSI 3.4%
    PRS 52.4%
  • GABAergic amacrine cell CL4030027
    CSI 1.1
    rCSI 3.7%
    PRS 54.0%
  • GABAergic neuron CL0000617
    CSI 1.1
    rCSI 3.7%
    PRS 50.5%
  • lung secretory cell CL1000272
    CSI 1.1
    rCSI 2.8%
    PRS 64.2%
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI 1.2
    rCSI 2.2%
    PRS 57.2%
  • retinal pigment epithelial cell CL0002586
    CSI 1.2
    rCSI 2.4%
    PRS 62.7%
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 1.2
    rCSI 1.5%
    PRS 74.5%
  • fibroblast of lung CL0002553
    CSI 1.3
    rCSI 1.2%
    PRS 66.4%
  • glutamatergic neuron CL0000679
    CSI 1.3
    rCSI 2.6%
    PRS 55.4%
  • L2/3 intratelencephalic projecting glutamatergic neuron CL4030059
    CSI 1.4
    rCSI 3.0%
    PRS 53.2%
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 1.4
    rCSI 1.1%
    PRS 66.7%
  • retinal cone cell CL0000573
    CSI 1.4
    rCSI 2.3%
    PRS 55.2%
  • basket cell CL0000118
    CSI 1.4
    rCSI 8.8%
    PRS 47.5%
  • regular atrial cardiac myocyte CL0002129
    CSI 1.4
    rCSI 4.5%
    PRS 63.4%
  • regular ventricular cardiac myocyte CL0002131
    CSI 1.4
    rCSI 8.9%
    PRS 57.3%
  • type B pancreatic cell CL0000169
    CSI 1.4
    rCSI 3.2%
    PRS 63.8%
  • lung neuroendocrine cell CL1000223
    CSI 1.4
    rCSI 2.1%
    PRS 71.0%
  • cardiac muscle cell CL0000746
    CSI 1.5
    rCSI 2.1%
    PRS 55.1%
  • glial cell CL0000125
    CSI 1.5
    rCSI 5.7%
    PRS 56.2%
  • Bergmann glial cell CL0000644
    CSI 1.5
    rCSI 2.0%
    PRS 58.5%
  • common dendritic progenitor CL0001029
    CSI 1.5
    rCSI 1.9%
    PRS 76.0%
  • lung ciliated cell CL1000271
    CSI 1.5
    rCSI 1.8%
    PRS 56.2%
  • nasal mucosa goblet cell CL0002480
    CSI 1.6
    rCSI 1.8%
    PRS 72.7%
  • epithelial cell of proximal tubule CL0002306
    CSI 1.6
    rCSI 3.9%
    PRS 58.7%
  • conjunctival epithelial cell CL1000432
    CSI 1.6
    rCSI 2.5%
    PRS 66.4%
  • amacrine cell CL0000561
    CSI 1.6
    rCSI 4.8%
    PRS 55.1%
  • cerebral cortex endothelial cell CL1001602
    CSI 1.7
    rCSI 2.9%
    PRS 56.0%
  • class switched memory B cell CL0000972
    CSI 1.7
    rCSI 1.3%
    PRS 81.6%
  • cardiac endothelial cell CL0010008
    CSI 1.7
    rCSI 7.0%
    PRS 64.8%
  • VIP GABAergic cortical interneuron CL4023016
    CSI 1.8
    rCSI 2.1%
    PRS 46.8%
  • sncg GABAergic cortical interneuron CL4023015
    CSI 1.8
    rCSI 2.8%
    PRS 49.0%
  • common myeloid progenitor CL0000049
    CSI 1.8
    rCSI 1.4%
    PRS 67.4%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 1.8
    rCSI 1.6%
    PRS 70.7%
  • renal beta-intercalated cell CL0002201
    CSI 1.9
    rCSI 4.5%
    PRS 66.1%
  • dopaminergic neuron CL0000700
    CSI 1.9
    rCSI 10.6%
    PRS 50.7%
  • choroid plexus epithelial cell CL0000706
    CSI 1.9
    rCSI 3.1%
    PRS 54.7%
  • Kupffer cell CL0000091
    CSI 1.9
    rCSI 4.4%
    PRS 65.7%
  • retinal rod cell CL0000604
    CSI 1.9
    rCSI 3.4%
    PRS 62.3%
  • naive T cell CL0000898
    CSI 2.0
    rCSI 1.4%
    PRS 80.8%
  • astrocyte of the cerebral cortex CL0002605
    CSI 2.0
    rCSI 4.5%
    PRS 47.7%
  • retinal bipolar neuron CL0000748
    CSI 2.0
    rCSI 3.8%
    PRS 53.7%
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 2.1
    rCSI 1.9%
    PRS 79.9%
  • blood vessel endothelial cell CL0000071
    CSI 2.1
    rCSI 4.3%
    PRS 62.8%
  • ciliated epithelial cell CL0000067
    CSI 2.1
    rCSI 1.8%
    PRS 53.6%
  • pancreatic A cell CL0000171
    CSI 2.1
    rCSI 2.2%
    PRS 69.2%
  • precursor B cell CL0000817
    CSI 2.2
    rCSI 1.9%
    PRS 74.7%
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 2.2
    rCSI 5.7%
    PRS 60.6%
  • hepatic stellate cell CL0000632
    CSI 2.2
    rCSI 8.3%
    PRS 57.6%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 2.3
    rCSI 1.5%
    PRS 79.0%
  • intestinal tuft cell CL0019032
    CSI 2.3
    rCSI 3.5%
    PRS 69.9%
  • chondrocyte CL0000138
    CSI 2.3
    rCSI 3.7%
    PRS 58.2%
  • Mueller cell CL0000636
    CSI 2.3
    rCSI 5.3%
    PRS 57.3%
  • indirect pathway medium spiny neuron CL4023029
    CSI 2.4
    rCSI 56.6%
    PRS 46.9%
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 2.4
    rCSI 2.7%
    PRS 58.6%
  • neural crest cell CL0011012
    CSI 2.4
    rCSI 1.9%
    PRS 52.6%
  • direct pathway medium spiny neuron CL4023026
    CSI 2.4
    rCSI 56.6%
    PRS 46.1%
  • pancreatic D cell CL0000173
    CSI 2.4
    rCSI 2.3%
    PRS 68.5%
  • vascular leptomeningeal cell CL4023051
    CSI 2.4
    rCSI 4.2%
    PRS 57.9%
  • cerebellar granule cell CL0001031
    CSI 2.4
    rCSI 3.6%
    PRS 58.8%
  • melanocyte CL0000148
    CSI 2.4
    rCSI 1.8%
    PRS 58.4%
  • interneuron CL0000099
    CSI 2.4
    rCSI 4.9%
    PRS 54.6%
  • hepatocyte CL0000182
    CSI 2.5
    rCSI 4.4%
    PRS 65.1%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 2.5
    rCSI 4.4%
    PRS 46.1%
  • naive B cell CL0000788
    CSI 2.6
    rCSI 2.2%
    PRS 73.3%
  • ependymal cell CL0000065
    CSI 2.6
    rCSI 5.3%
    PRS 44.4%
  • renal alpha-intercalated cell CL0005011
    CSI 2.6
    rCSI 3.5%
    PRS 74.3%
  • group 3 innate lymphoid cell CL0001071
    CSI 2.6
    rCSI 2.0%
    PRS 71.4%
  • pvalb GABAergic cortical interneuron CL4023018
    CSI 2.7
    rCSI 3.3%
    PRS 45.2%
  • cardiac neuron CL0010022
    CSI 2.8
    rCSI 8.8%
    PRS 62.7%
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI 2.9
    rCSI 16.9%
    PRS 48.2%
  • alveolar macrophage CL0000583
    CSI 2.9
    rCSI 4.9%
    PRS 70.9%
  • IgA plasma cell CL0000987
    CSI 3.0
    rCSI 3.1%
    PRS 78.6%
  • double negative thymocyte CL0002489
    CSI 3.0
    rCSI 2.1%
    PRS 76.9%
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 3.1
    rCSI 11.8%
    PRS 47.7%
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 3.1
    rCSI 1.9%
    PRS 82.8%
  • ciliated cell CL0000064
    CSI 3.2
    rCSI 5.2%
    PRS 61.9%
  • mesothelial cell CL0000077
    CSI 3.3
    rCSI 12.9%
    PRS 42.5%
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 3.4
    rCSI 2.6%
    PRS 78.9%
  • inhibitory interneuron CL0000498
    CSI 3.6
    rCSI 8.3%
    PRS 54.2%
  • fibroblast of cardiac tissue CL0002548
    CSI 3.8
    rCSI 18.3%
    PRS 65.6%
  • alveolar adventitial fibroblast CL4028006
    CSI 4.2
    rCSI 6.6%
    PRS 68.2%
  • cerebral cortex neuron CL0010012
    CSI 4.4
    rCSI 17.9%
    PRS 59.3%
  • L6b glutamatergic cortical neuron CL4023038
    CSI 4.5
    rCSI 14.0%
    PRS 48.8%
  • renal interstitial pericyte CL1001318
    CSI 4.5
    rCSI 12.5%
    PRS 60.9%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 4.9
    rCSI 8.2%
    PRS 47.0%
  • mucosal invariant T cell CL0000940
    CSI 4.9
    rCSI 4.0%
    PRS 76.1%
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 5.2
    rCSI 13.5%
    PRS 65.4%
  • sst GABAergic cortical interneuron CL4023017
    CSI 6.9
    rCSI 8.9%
    PRS 48.3%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 7.1
    rCSI 17.2%
    PRS 45.5%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [MTOR](/details-gene/2475) (mechanistic target of rapamycin kinase) is a protein-coding gene located on chromosome 1p36.22 that encodes a highly conserved serine/threonine protein kinase. This kinase is a central regulator of fundamental cellular processes including growth, proliferation, metabolism, and survival. As a key component of two distinct protein complexes, mTORC1 and mTORC2, [MTOR](/details-gene/2475) functions as a sensor that integrates diverse environmental and intracellular signals, such as nutrients (amino acids), growth factors (insulin), and cellular energy status. Its function is implicated in a vast array of biological processes, from [T cell costimulation](/details-ontology/GO0031295) and [macroautophagy](/details-ontology/GO0016236) to [cardiac muscle cell development](/details-ontology/GO0055013) and [oligodendrocyte differentiation](/details-ontology/GO0048709). Expression data highlights its critical role in cells with high metabolic and biosynthetic demands, showing particular significance in [erythroblast](/details-cell/CL0000765)s and various subtypes of cortical neurons. Clinically, dysregulation of the mTOR pathway is a hallmark of numerous diseases, including cancer and metabolic disorders, making it a prominent therapeutic target ([OMIM: 601231](https://omim.org/entry/601231)). ## Cellular Roles and Expression Landscape The expression profile of [MTOR](/details-gene/2475) underscores its role as a master regulator in metabolically active and developing cells across multiple lineages. **Overall**, the gene exhibits its highest significance in the context of hematopoiesis, specifically within [erythroblast](/details-cell/CL0000765)s (CSI: 13.01). This suggests an essential function in coordinating the massive burst of protein synthesis and cell growth required for red blood cell maturation. Beyond the hematopoietic system, [MTOR](/details-gene/2475) is a key player in the central nervous system. It shows high significance in several distinct neuronal populations, including [L5 extratelencephalic projecting glutamatergic cortical neuron](/details-cell/CL4023041) (CSI: 9.42), [retina horizontal cell](/details-cell/CL0000745) (CSI: 8.96), and multiple intratelencephalic and inhibitory interneurons. This pattern indicates a crucial role in neuronal development, synaptic plasticity, and metabolic maintenance. The gene also demonstrates significant expression in specialized epithelial and stromal cells, such as [kidney connecting tubule epithelial cell](/details-cell/CL1000768) (CSI: 7.42), [alveolar adventitial fibroblast](/details-cell/CL4028006) (CSI: 4.17), and [renal interstitial pericyte](/details-cell/CL1001318) (CSI: 4.52), consistent with its involvement in tissue homeostasis and repair. Its moderate significance in immune cells like [kidney interstitial alternatively activated macrophage](/details-cell/CL1000695) and [mucosal invariant T cell](/details-cell/CL0000940) aligns with its established role in immune cell activation and differentiation. The broad but potent expression across these diverse cell types highlights [MTOR](/details-gene/2475) as a fundamental hub for cellular decision-making rather than a lineage-defining marker. ## Pathways and Molecular Function [MTOR](/details-gene/2475) functions as a catalytic subunit within two structurally and functionally distinct complexes, mTORC1 and mTORC2, which orchestrate a wide range of cellular activities. Its molecular function is primarily that of a [protein serine/threonine kinase activity](/details-ontology/GO0004674), enabling it to phosphorylate a multitude of downstream substrates. The gene is central to the [TOR signaling](/details-ontology/GO0031929) pathway, which is a critical integrator of environmental cues. Functional annotations show its involvement in responding to nutrient availability ([Cellular response to nutrient levels](/details-ontology/GO0031669)), amino acids ([Cellular response to l-leucine](/details-ontology/GO0071233)), and growth factor signals ([Cellular response to insulin stimulus](/details-ontology/GO0032869)). The Reactome database further clarifies these connections, detailing its roles in [Amino acids regulate mtorc1](/details-pathway/R-HSA-9639288) and [Pip3 activates akt signaling](/details-pathway/R-HSA-1257604). Upon activation, mTORC1 promotes anabolic processes to fuel cell growth. This includes the [positive regulation of translation](/details-ontology/GO0045727) and [lipid biosynthetic process](/details-ontology/GO0046889). Concurrently, it suppresses catabolic processes, most notably through the [negative regulation of macroautophagy](/details-ontology/GO0016242), preventing cellular self-digestion when resources are plentiful. Its role in the [Adaptive immune system](/details-pathway/R-HSA-1280218), particularly through pathways like [Cd28 co-stimulation](/details-pathway/R-HSA-389356), is consistent with its significance in T cells and macrophages. The kinase's activity is supported by its localization to various cellular compartments, including the [cytoplasm](/details-ontology/GO0005737), [nucleus](/details-ontology/GO0005634), and membranes of the lysosome and mitochondria, positioning it to receive and transmit signals from diverse sources [Link](https://pubmed.ncbi.nlm.nih.gov/11930000/). ## Research Directions The ubiquitous and critical nature of [MTOR](/details-gene/2475) signaling makes it a central focus of biomedical research, with many questions remaining about its cell-type-specific regulation and functions. ### Proposed Hypotheses 1. **Erythroid-Specific Regulation:** The exceptionally high significance of [MTOR](/details-gene/2475) in [erythroblast](/details-cell/CL0000765)s suggests that its activity is not merely permissive but is actively modulated by core erythroid transcription factors (e.g., GATA1, KLF1). We hypothesize that these factors create a feed-forward loop, directly enhancing mTORC1 activity or expression to ensure that the massive biosynthetic demands of hemoglobin production are met and coupled to nutrient availability. 2. **Neuronal Subtype Plasticity:** The distinctively high significance of [MTOR](/details-gene/2475) in specific long-range projecting glutamatergic neurons ([L5 extratelencephalic projecting glutamatergic cortical neuron](/details-cell/CL4023041)) compared to other neuronal subtypes suggests a specialized role. We hypothesize that in these neurons, [MTOR](/details-gene/2475) signaling is spatially regulated within dendrites and axons to control local protein synthesis, which is critical for maintaining synaptic strength and structural integrity over long distances. ### Key Experiment To test the hypothesis of erythroid-specific regulation of [MTOR](/details-gene/2475), a multi-omics approach in a primary human hematopoietic stem and progenitor cell (HSPC) model could be employed. Differentiating these cells *in vitro* towards the erythroid lineage would provide a dynamic system for analysis. Chromatin Immunoprecipitation followed by sequencing (ChIP-seq) for GATA1 could be used to determine if it binds to regulatory regions of [MTOR](/details-gene/2475) or its key regulators. In parallel, a proximity-ligation assay (e.g., BioID) using GATA1 as bait could identify direct or indirect protein-protein interactions with components of the mTORC1/mTORC2 complexes, revealing a potential physical link between the lineage-defining transcription factor and the metabolic machinery. ### Therapeutic Potential [MTOR](/details-gene/2475) is a validated and high-value therapeutic target, primarily for **inhibition**. Its central role in promoting cell growth and proliferation makes it a prime target in oncology, where pathways upstream of mTOR (e.g., PI3K/AKT) are frequently hyperactivated. Rapamycin and its analogs (rapalogs) are clinically approved mTOR inhibitors. The data's confirmation of its high importance in diverse cell types like neurons and erythroblasts aligns with the known side-effect profiles of mTOR inhibitors, which can include metabolic dysregulation, hematological abnormalities, and immunosuppression. Future therapeutic strategies aim to improve specificity, either by developing inhibitors that selectively target mTORC1 over mTORC2 or by creating drug delivery systems that concentrate inhibitors in target tissues (e.g., tumors) to minimize systemic toxicity.

Genular Protein ID: 2467388000

Symbol: MTOR_HUMAN

Name: FK506-binding protein 12-rapamycin complex-associated protein 1

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 8008069

Title: A mammalian protein targeted by G1-arresting rapamycin-receptor complex.

PubMed ID: 8008069

DOI: 10.1038/369756a0

PubMed ID: 9653645

Title: Molecular cloning and expression analysis of five novel genes in chromosome 1p36.

PubMed ID: 9653645

DOI: 10.1006/geno.1997.5186

PubMed ID: 16710414

Title: The DNA sequence and biological annotation of human chromosome 1.

PubMed ID: 16710414

DOI: 10.1038/nature04727

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 11426320

Title: The human gene for mannan-binding lectin-associated serine protease-2 (MASP-2), the effector component of the lectin route of complement activation, is part of a tightly linked gene cluster on chromosome 1p36.2-3.

PubMed ID: 11426320

DOI: 10.1038/sj.gene.6363745

PubMed ID: 7809080

Title: RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.

PubMed ID: 7809080

DOI: 10.1073/pnas.91.26.12574

PubMed ID: 9434772

Title: Expression, enzyme activity, and subcellular localization of mammalian target of rapamycin in insulin-responsive cells.

PubMed ID: 9434772

DOI: 10.1006/bbrc.1997.7878

PubMed ID: 11853878

Title: Characterization of ubiquilin 1, an mTOR-interacting protein.

PubMed ID: 11853878

DOI: 10.1016/s0167-4889(01)00164-1

PubMed ID: 12150925

Title: mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the growth machinery.

PubMed ID: 12150925

DOI: 10.1016/s0092-8674(02)00808-5

PubMed ID: 12150926

Title: Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.

PubMed ID: 12150926

DOI: 10.1016/s0092-8674(02)00833-4

PubMed ID: 12231510

Title: The FKBP12-rapamycin-associated protein (FRAP) is a CLIP-170 kinase.

PubMed ID: 12231510

DOI: 10.1093/embo-reports/kvf197

PubMed ID: 12087098

Title: Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin.

PubMed ID: 12087098

DOI: 10.1074/jbc.m204080200

PubMed ID: 12408816

Title: Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.

PubMed ID: 12408816

DOI: 10.1016/s1097-2765(02)00636-6

PubMed ID: 11930000

Title: FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction.

PubMed ID: 11930000

DOI: 10.1073/pnas.261702698

PubMed ID: 14651849

Title: TSC2 mediates cellular energy response to control cell growth and survival.

PubMed ID: 14651849

DOI: 10.1016/s0092-8674(03)00929-2

PubMed ID: 12718876

Title: GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR.

PubMed ID: 12718876

DOI: 10.1016/s1097-2765(03)00114-x

PubMed ID: 15268862

Title: Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

PubMed ID: 15268862

DOI: 10.1016/j.cub.2004.06.054

PubMed ID: 15545625

Title: Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

PubMed ID: 15545625

DOI: 10.1101/gad.1256804

PubMed ID: 14578359

Title: FKBP12-rapamycin-associated protein or mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the Golgi apparatus.

PubMed ID: 14578359

DOI: 10.1074/jbc.m305912200

PubMed ID: 15467718

Title: Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.

PubMed ID: 15467718

DOI: 10.1038/ncb1183

PubMed ID: 15905173

Title: Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase.

PubMed ID: 15905173

DOI: 10.1074/jbc.m504045200

PubMed ID: 15718470

Title: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

PubMed ID: 15718470

DOI: 10.1126/science.1106148

PubMed ID: 17517883

Title: The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.

PubMed ID: 17517883

DOI: 10.1074/jbc.m702636200

PubMed ID: 17599906

Title: PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.

PubMed ID: 17599906

DOI: 10.1074/jbc.m704343200

PubMed ID: 17386266

Title: PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase.

PubMed ID: 17386266

DOI: 10.1016/j.molcel.2007.03.003

PubMed ID: 18925875

Title: mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).

PubMed ID: 18925875

DOI: 10.1042/bj20081668

PubMed ID: 18762023

Title: SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth.

PubMed ID: 18762023

DOI: 10.1016/j.cmet.2008.07.007

PubMed ID: 18372248

Title: Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation.

PubMed ID: 18372248

DOI: 10.1074/jbc.m800723200

PubMed ID: 18691976

Title: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.

PubMed ID: 18691976

DOI: 10.1016/j.molcel.2008.07.007

PubMed ID: 18669648

Title: A quantitative atlas of mitotic phosphorylation.

PubMed ID: 18669648

DOI: 10.1073/pnas.0805139105

PubMed ID: 18497260

Title: The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.

PubMed ID: 18497260

DOI: 10.1126/science.1157535

PubMed ID: 19446321

Title: DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.

PubMed ID: 19446321

DOI: 10.1016/j.cell.2009.03.046

PubMed ID: 19487463

Title: Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth.

PubMed ID: 19487463

DOI: 10.1128/mcb.01665-08

PubMed ID: 19369195

Title: Large-scale proteomics analysis of the human kinome.

PubMed ID: 19369195

DOI: 10.1074/mcp.m800588-mcp200

PubMed ID: 19608861

Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.

PubMed ID: 19608861

DOI: 10.1126/science.1175371

PubMed ID: 19145465

Title: mTOR phosphorylated at S2448 binds to raptor and rictor.

PubMed ID: 19145465

DOI: 10.1007/s00726-008-0230-7

PubMed ID: 20381137

Title: Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids.

PubMed ID: 20381137

DOI: 10.1016/j.cell.2010.02.024

PubMed ID: 20537536

Title: DAP1, a novel substrate of mTOR, negatively regulates autophagy.

PubMed ID: 20537536

DOI: 10.1016/j.cub.2010.04.041

PubMed ID: 20810650

Title: A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability.

PubMed ID: 20810650

DOI: 10.1101/gad.1934210

PubMed ID: 20801936

Title: Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes.

PubMed ID: 20801936

DOI: 10.1101/gad.1956410

PubMed ID: 20427287

Title: Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly.

PubMed ID: 20427287

DOI: 10.1074/jbc.m110.121699

PubMed ID: 20516213

Title: mTORC1 directly phosphorylates and regulates human MAF1.

PubMed ID: 20516213

DOI: 10.1128/mcb.00319-10

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21576368

Title: mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression.

PubMed ID: 21576368

DOI: 10.1128/mcb.05437-11

PubMed ID: 21406692

Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

PubMed ID: 21406692

DOI: 10.1126/scisignal.2001570

PubMed ID: 21659604

Title: The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.

PubMed ID: 21659604

DOI: 10.1126/science.1199498

PubMed ID: 22576015

Title: MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB.

PubMed ID: 22576015

DOI: 10.4161/auto.19653

PubMed ID: 22343943

Title: A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB.

PubMed ID: 22343943

DOI: 10.1038/emboj.2012.32

PubMed ID: 22692423

Title: The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis.

PubMed ID: 22692423

DOI: 10.1126/scisignal.2002790

PubMed ID: 23027611

Title: 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia.

PubMed ID: 23027611

DOI: 10.1002/emmm.201201410

PubMed ID: 22814378

Title: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

PubMed ID: 22814378

DOI: 10.1073/pnas.1210303109

PubMed ID: 23394946

Title: mTOR regulates lysosomal ATP-sensitive two-pore Na(+) channels to adapt to metabolic state.

PubMed ID: 23394946

DOI: 10.1016/j.cell.2013.01.023

PubMed ID: 23426360

Title: Phosphorylation of lipin 1 and charge on the phosphatidic acid head group control its phosphatidic acid phosphatase activity and membrane association.

PubMed ID: 23426360

DOI: 10.1074/jbc.m112.441493

PubMed ID: 25657994

Title: The potential role of BRCA1-associated ATM activator-1 (BRAT1) in regulation of mTOR.

PubMed ID: 25657994

PubMed ID: 24247430

Title: Phosphorylation of the TOR ATP binding domain by AGC kinase constitutes a novel mode of TOR inhibition.

PubMed ID: 24247430

DOI: 10.1083/jcb.201305103

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 23524951

Title: mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6.

PubMed ID: 23524951

DOI: 10.1038/ncb2708

PubMed ID: 23762398

Title: Interaction between NBS1 and the mTOR/Rictor/SIN1 complex through specific domains.

PubMed ID: 23762398

DOI: 10.1371/journal.pone.0065586

PubMed ID: 23429704

Title: Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis.

PubMed ID: 23429704

DOI: 10.1126/science.1228771

PubMed ID: 23429703

Title: Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1.

PubMed ID: 23429703

DOI: 10.1126/science.1228792

PubMed ID: 24403073

Title: Characterization of the Raptor/4E-BP1 interaction by chemical cross-linking coupled with mass spectrometry analysis.

PubMed ID: 24403073

DOI: 10.1074/jbc.m113.482067

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 24448649

Title: The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris.

PubMed ID: 24448649

DOI: 10.1126/scisignal.2004754

PubMed ID: 25851998

Title: A germline MTOR mutation in Aboriginal Australian siblings with intellectual disability, dysmorphism, macrocephaly, and small thoraces.

PubMed ID: 25851998

DOI: 10.1002/ajmg.a.37070

PubMed ID: 26018084

Title: Somatic mutations in the MTOR gene cause focal cortical dysplasia type IIb.

PubMed ID: 26018084

DOI: 10.1002/ana.24444

PubMed ID: 26542245

Title: Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities.

PubMed ID: 26542245

DOI: 10.1186/s12881-015-0240-8

PubMed ID: 25438055

Title: AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation.

PubMed ID: 25438055

DOI: 10.1038/ncb3072

PubMed ID: 25799227

Title: Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.

PubMed ID: 25799227

DOI: 10.1038/nm.3824

PubMed ID: 25561175

Title: SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1.

PubMed ID: 25561175

DOI: 10.1038/nature14107

PubMed ID: 25878179

Title: Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR.

PubMed ID: 25878179

DOI: 10.1212/wnl.0000000000001594

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

PubMed ID: 25567906

Title: Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1.

PubMed ID: 25567906

DOI: 10.1126/science.1257132

PubMed ID: 26812014

Title: WAC regulates mTOR activity by acting as an adaptor for the TTT and Pontin/Reptin complexes.

PubMed ID: 26812014

DOI: 10.1016/j.devcel.2015.12.019

PubMed ID: 27623384

Title: PIKfyve Regulates Vacuole Maturation and Nutrient Recovery following Engulfment.

PubMed ID: 27623384

DOI: 10.1016/j.devcel.2016.08.001

PubMed ID: 27830187

Title: Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy.

PubMed ID: 27830187

DOI: 10.1212/nxg.0000000000000118

PubMed ID: 29750193

Title: Mammalian EAK-7 activates alternative mTOR signaling to regulate cell proliferation and migration.

PubMed ID: 29750193

DOI: 10.1126/sciadv.aao5838

PubMed ID: 29150432

Title: The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists.

PubMed ID: 29150432

DOI: 10.15252/embj.201696164

PubMed ID: 30956113

Title: Transmembrane 4 L six family member 5 senses arginine for mTORC1 signaling.

PubMed ID: 30956113

DOI: 10.1016/j.cmet.2019.03.005

PubMed ID: 30704899

Title: Pacer is a mediator of mTORC1 and GSK3-TIP60 signaling in regulation of autophagosome maturation and lipid metabolism.

PubMed ID: 30704899

DOI: 10.1016/j.molcel.2018.12.017

PubMed ID: 31112131

Title: GPCR signaling inhibits mTORC1 via PKA phosphorylation of Raptor.

PubMed ID: 31112131

DOI: 10.7554/elife.43038

PubMed ID: 31695197

Title: Lipid signalling drives proteolytic rewiring of mitochondria by YME1L.

PubMed ID: 31695197

DOI: 10.1038/s41586-019-1738-6

PubMed ID: 31036939

Title: The lysosomal GPCR-like protein GPR137B regulates Rag and mTORC1 localization and activity.

PubMed ID: 31036939

DOI: 10.1038/s41556-019-0321-6

PubMed ID: 31601708

Title: Structural basis for the docking of mTORC1 on the lysosomal surface.

PubMed ID: 31601708

DOI: 10.1126/science.aay0166

PubMed ID: 33378666

Title: mTORC2 Assembly Is Regulated by USP9X-Mediated Deubiquitination of RICTOR.

PubMed ID: 33378666

DOI: 10.1016/j.celrep.2020.108564

PubMed ID: 32612235

Title: A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dube syndrome.

PubMed ID: 32612235

DOI: 10.1038/s41586-020-2444-0

PubMed ID: 32561715

Title: Leucine regulates autophagy via acetylation of the mTORC1 component raptor.

PubMed ID: 32561715

DOI: 10.1038/s41467-020-16886-2

PubMed ID: 32647003

Title: HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease.

PubMed ID: 32647003

DOI: 10.1126/science.aay5663

PubMed ID: 34289345

Title: Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway.

PubMed ID: 34289345

DOI: 10.1016/j.cell.2021.06.028

PubMed ID: 35561222

Title: SNAT7 regulates mTORC1 via macropinocytosis.

PubMed ID: 35561222

DOI: 10.1073/pnas.2123261119

PubMed ID: 35904232

Title: TSPAN8 alleviates high glucose-induced apoptosis and autophagy via targeting mTORC2.

PubMed ID: 35904232

DOI: 10.1002/cbin.11870

PubMed ID: 36691768

Title: TORC1 phosphorylates and inhibits the ribosome preservation factor Stm1 to activate dormant ribosomes.

PubMed ID: 36691768

DOI: 10.15252/embj.2022112344

PubMed ID: 37057673

Title: De novo missense variants in RRAGC lead to a fatal mTORopathy of early childhood.

PubMed ID: 37057673

DOI: 10.1016/j.gim.2023.100838

PubMed ID: 36608670

Title: A central role for regulated protein stability in the control of TFE3 and MITF by nutrients.

PubMed ID: 36608670

DOI: 10.1016/j.molcel.2022.12.013

PubMed ID: 37751742

Title: Lysosomal cyst(e)ine storage potentiates tolerance to oxidative stress in cancer cells.

PubMed ID: 37751742

DOI: 10.1016/j.molcel.2023.08.032

PubMed ID: 8662507

Title: Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP.

PubMed ID: 8662507

DOI: 10.1126/science.273.5272.239

PubMed ID: 10089303

Title: Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.

PubMed ID: 10089303

DOI: 10.1107/s0907444998014747

PubMed ID: 20060908

Title: Insights into the domain and repeat architecture of target of rapamycin.

PubMed ID: 20060908

DOI: 10.1016/j.jsb.2010.01.002

PubMed ID: 20542007

Title: Structure of the human mTOR complex I and its implications for rapamycin inhibition.

PubMed ID: 20542007

DOI: 10.1016/j.molcel.2010.05.017

PubMed ID: 23636326

Title: mTOR kinase structure, mechanism and regulation.

PubMed ID: 23636326

DOI: 10.1038/nature12122

PubMed ID: 27909983

Title: 4.4 Aa Resolution Cryo-EM structure of human mTOR Complex 1.

PubMed ID: 27909983

DOI: 10.1007/s13238-016-0346-6

PubMed ID: 26678875

Title: Architecture of human mTOR complex 1.

PubMed ID: 26678875

DOI: 10.1126/science.aaa3870

PubMed ID: 29236692

Title: Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40.

PubMed ID: 29236692

DOI: 10.1038/nature25023

PubMed ID: 31601764

Title: Architecture of human Rag GTPase heterodimers and their complex with mTORC1.

PubMed ID: 31601764

DOI: 10.1126/science.aax3939

PubMed ID: 34519268

Title: Regulation of human mTOR complexes by DEPTOR.

PubMed ID: 34519268

DOI: 10.7554/elife.70871

PubMed ID: 34519269

Title: Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace.

PubMed ID: 34519269

DOI: 10.7554/elife.68799

PubMed ID: 36697823

Title: Structure of the lysosomal mTORC1-TFEB-Rag-Ragulator megacomplex.

PubMed ID: 36697823

DOI: 10.1038/s41586-022-05652-7

PubMed ID: 17344846

Title: Patterns of somatic mutation in human cancer genomes.

PubMed ID: 17344846

DOI: 10.1038/nature05610

PubMed ID: 21248752

Title: Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.

PubMed ID: 21248752

DOI: 10.1038/nature09639

Sequence Information:

  • Length: 2549
  • Mass: 288892
  • Checksum: 7D9AD6E784882AB4
  • Sequence:
  • MLGTGPAAAT TAATTSSNVS VLQQFASGLK SRNEETRAKA AKELQHYVTM ELREMSQEES 
    TRFYDQLNHH IFELVSSSDA NERKGGILAI ASLIGVEGGN ATRIGRFANY LRNLLPSNDP 
    VVMEMASKAI GRLAMAGDTF TAEYVEFEVK RALEWLGADR NEGRRHAAVL VLRELAISVP 
    TFFFQQVQPF FDNIFVAVWD PKQAIREGAV AALRACLILT TQREPKEMQK PQWYRHTFEE 
    AEKGFDETLA KEKGMNRDDR IHGALLILNE LVRISSMEGE RLREEMEEIT QQQLVHDKYC 
    KDLMGFGTKP RHITPFTSFQ AVQPQQSNAL VGLLGYSSHQ GLMGFGTSPS PAKSTLVESR 
    CCRDLMEEKF DQVCQWVLKC RNSKNSLIQM TILNLLPRLA AFRPSAFTDT QYLQDTMNHV 
    LSCVKKEKER TAAFQALGLL SVAVRSEFKV YLPRVLDIIR AALPPKDFAH KRQKAMQVDA 
    TVFTCISMLA RAMGPGIQQD IKELLEPMLA VGLSPALTAV LYDLSRQIPQ LKKDIQDGLL 
    KMLSLVLMHK PLRHPGMPKG LAHQLASPGL TTLPEASDVG SITLALRTLG SFEFEGHSLT 
    QFVRHCADHF LNSEHKEIRM EAARTCSRLL TPSIHLISGH AHVVSQTAVQ VVADVLSKLL 
    VVGITDPDPD IRYCVLASLD ERFDAHLAQA ENLQALFVAL NDQVFEIREL AICTVGRLSS 
    MNPAFVMPFL RKMLIQILTE LEHSGIGRIK EQSARMLGHL VSNAPRLIRP YMEPILKALI 
    LKLKDPDPDP NPGVINNVLA TIGELAQVSG LEMRKWVDEL FIIIMDMLQD SSLLAKRQVA 
    LWTLGQLVAS TGYVVEPYRK YPTLLEVLLN FLKTEQNQGT RREAIRVLGL LGALDPYKHK 
    VNIGMIDQSR DASAVSLSES KSSQDSSDYS TSEMLVNMGN LPLDEFYPAV SMVALMRIFR 
    DQSLSHHHTM VVQAITFIFK SLGLKCVQFL PQVMPTFLNV IRVCDGAIRE FLFQQLGMLV 
    SFVKSHIRPY MDEIVTLMRE FWVMNTSIQS TIILLIEQIV VALGGEFKLY LPQLIPHMLR 
    VFMHDNSPGR IVSIKLLAAI QLFGANLDDY LHLLLPPIVK LFDAPEAPLP SRKAALETVD 
    RLTESLDFTD YASRIIHPIV RTLDQSPELR STAMDTLSSL VFQLGKKYQI FIPMVNKVLV 
    RHRINHQRYD VLICRIVKGY TLADEEEDPL IYQHRMLRSG QGDALASGPV ETGPMKKLHV 
    STINLQKAWG AARRVSKDDW LEWLRRLSLE LLKDSSSPSL RSCWALAQAY NPMARDLFNA 
    AFVSCWSELN EDQQDELIRS IELALTSQDI AEVTQTLLNL AEFMEHSDKG PLPLRDDNGI 
    VLLGERAAKC RAYAKALHYK ELEFQKGPTP AILESLISIN NKLQQPEAAA GVLEYAMKHF 
    GELEIQATWY EKLHEWEDAL VAYDKKMDTN KDDPELMLGR MRCLEALGEW GQLHQQCCEK 
    WTLVNDETQA KMARMAAAAA WGLGQWDSME EYTCMIPRDT HDGAFYRAVL ALHQDLFSLA 
    QQCIDKARDL LDAELTAMAG ESYSRAYGAM VSCHMLSELE EVIQYKLVPE RREIIRQIWW 
    ERLQGCQRIV EDWQKILMVR SLVVSPHEDM RTWLKYASLC GKSGRLALAH KTLVLLLGVD 
    PSRQLDHPLP TVHPQVTYAY MKNMWKSARK IDAFQHMQHF VQTMQQQAQH AIATEDQQHK 
    QELHKLMARC FLKLGEWQLN LQGINESTIP KVLQYYSAAT EHDRSWYKAW HAWAVMNFEA 
    VLHYKHQNQA RDEKKKLRHA SGANITNATT AATTAATATT TASTEGSNSE SEAESTENSP 
    TPSPLQKKVT EDLSKTLLMY TVPAVQGFFR SISLSRGNNL QDTLRVLTLW FDYGHWPDVN 
    EALVEGVKAI QIDTWLQVIP QLIARIDTPR PLVGRLIHQL LTDIGRYHPQ ALIYPLTVAS 
    KSTTTARHNA ANKILKNMCE HSNTLVQQAM MVSEELIRVA ILWHEMWHEG LEEASRLYFG 
    ERNVKGMFEV LEPLHAMMER GPQTLKETSF NQAYGRDLME AQEWCRKYMK SGNVKDLTQA 
    WDLYYHVFRR ISKQLPQLTS LELQYVSPKL LMCRDLELAV PGTYDPNQPI IRIQSIAPSL 
    QVITSKQRPR KLTLMGSNGH EFVFLLKGHE DLRQDERVMQ LFGLVNTLLA NDPTSLRKNL 
    SIQRYAVIPL STNSGLIGWV PHCDTLHALI RDYREKKKIL LNIEHRIMLR MAPDYDHLTL 
    MQKVEVFEHA VNNTAGDDLA KLLWLKSPSS EVWFDRRTNY TRSLAVMSMV GYILGLGDRH 
    PSNLMLDRLS GKILHIDFGD CFEVAMTREK FPEKIPFRLT RMLTNAMEVT GLDGNYRITC 
    HTVMEVLREH KDSVMAVLEA FVYDPLLNWR LMDTNTKGNK RSRTRTDSYS AGQSVEILDG 
    VELGEPAHKK TGTTVPESIH SFIGDGLVKP EALNKKAIQI INRVRDKLTG RDFSHDDTLD 
    VPTQVELLIK QATSHENLCQ CYIGWCPFW

Genular Protein ID: 3439601957

Symbol: A0A8V8TQ52_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11237011

Title: Initial sequencing and analysis of the human genome.

PubMed ID: 11237011

DOI: 10.1038/35057062

PubMed ID: 15496913

Title: Finishing the euchromatic sequence of the human genome.

PubMed ID: 15496913

DOI: 10.1038/nature03001

PubMed ID: 16710414

Title: The DNA sequence and biological annotation of human chromosome 1.

PubMed ID: 16710414

DOI: 10.1038/nature04727

Sequence Information:

  • Length: 1590
  • Mass: 178743
  • Checksum: 2FE43AC7D0819C22
  • Sequence:
  • MLGTGPAAAT TAATTSSNVS VLQQFASGLK SRNEETRAKA AKELQHYVTM ELREMSQEES 
    TRFYDQLNHH IFELVSSSDA NERKGGILAI ASLIGVEGGN ATRIGRFANY LRNLLPSNDP 
    VVMEMASKAI GRLAMAGDTF TAEYVEFEVK RALEWLGADR NEGRRHAAVL VLRELAISVP 
    TFFFQQVQPF FDNIFVAVWD PKQAIREGAV AALRACLILT TQREPKEMQK PQWYRHTFEE 
    AEKGFDETLA KEKGMNRDDR IHGALLILNE LVRISSMEGE RLREEMEEIT QQQLVHDKYC 
    KDLMGFGTKP RHITPFTSFQ AVQPQQSNAL VGLLGYSSHQ GLMGFGTSPS PAKSTLVESR 
    CCRDLMEEKF DQVCQWVLKC RNSKNSLIQM TILNLLPRLA AFRPSAFTDT QYLQDTMNHV 
    LSCVKKEKER TAAFQALGLL SVAVRSEFKV YLPRVLDIIR AALPPKDFAH KRQKAMQVDA 
    TVFTCISMLA RAMGPGIQQD IKELLEPMLA VGLSPALTAV LYDLSRQIPQ LKKDIQDGLL 
    KMLSLVLMHK PLRHPGMPKG LAHQLASPGL TTLPEASDVG SITLALRTLG SFEFEGHSLT 
    QFVRHCADHF LNSEHKEIRM EAARTCSRLL TPSIHLISGH AHVVSQTAVQ VVADVLSKLL 
    VVGITDPDPD IRYCVLASLD ERFDAHLAQA ENLQALFVAL NDQVFEIREL AICTVGRLSS 
    MNPAFVMPFL RKMLIQILTE LEHSGIGRIK EQSARMLGHL VSNAPRLIRP YMEPILKALI 
    LKLKDPDPDP NPGVINNVLA TIGELAQVSG LEMRKWVDEL FIIIMDMLQD SSLLAKRQVA 
    LWTLGQLVAS TGYVVEPYRK YPTLLEVLLN FLKTEQNQGT RREAIRVLGL LGALDPYKHK 
    VNIGMIDQSR DASAVSLSES KSSQDSSDYS TSEMLVNMGN LPLDEFYPAV SMVALMRIFR 
    DQSLSHHHTM VVQAITFIFK SLGLKCVQFL PQVMPTFLNV IRVCDGAIRE FLFQQLGMLV 
    SFVKSHIRPY MDEIVTLMRE FWVMNTSIQS TIILLIEQIV VALGGEFKLY LPQLIPHMLR 
    VFMHDNSPGR IVSIKLLAAI QLFGANLDDY LHLLLPPIVK LFDAPEAPLP SRKAALETVD 
    RLTESLDFTD YASRIIHPIV RTLDQSPELR STAMDTLSSL VFQLGKKYQI FIPMVNKVLV 
    RHRINHQRYD VLICRIVKGY TLADEEEDPL IYQHRMLRSG QGDALASGPV ETGPMKKLHV 
    STINLQKAWG AARRVSKDDW LEWLRRLSLE LLKDSSSPSL RSCWALAQAY NPMARDLFNA 
    AFVSCWSELN EDQQDELIRS IELALTSQDI AEVTQTLLNL AEFMEHSDKG PLPLRDDNGI 
    VLLGERAAKC RAYAKALHYK ELEFQKGPTP AILESLISIN NKLQQPEAAA GVLEYAMKHF 
    GELEIQATWY EKLHEWEDAL VAYDKKMDTN KDDPELMLGR MRCLEALGEW GQLHQQCCEK 
    WTLVNDETQA KMARMAAAAA WGLGQWDSME EYTCMIPRDT HDGAFYRAVL ALHQDLFSLA 
    QQCIDKARDL LDAELTAMAG ESYSRAYGIP